CDMO & CRO Industry: 5 Year Valuation History

CDMO & CRO Industry: 5 Year Valuation History

CDMO multiples continue to hit record highs as companies pursue consolidation in an effort to become full-service providers. Similarly, CRO multiples remain at historically elevated levels with sponsors continuing to look toward outsourcing as pharma companies find it increasingly difficult to navigate the regulatory landscape.

For additional research in the CRO and CDMO spaces, please review our full sector snapshots.

By | 2019-01-04T17:25:50+00:00 January 3rd, 2019|Comments Off on CDMO & CRO Industry: 5 Year Valuation History

About the Author: